Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Antti Siltanen

Analyst

Antti Siltanen portrait

Coverage

Herantis PharmaNexstimFaron PharmaceuticalsNightingale HealthBioretecAiforia TechnologiesBiohitOrionModulight

Latest content

ShowingAll content types

US market roadmap for medical devices – a European perspective

Analyst Comment 27.03.2026, 11.45 by Antti Siltanen
BioretecAiforia TechnologiesNightingale HealthNexstim

Nexstim received new sales clearances in the United States

Analyst Comment 24.03.2026, 08.18 by Antti Siltanen
Nexstim

Aiforia secures another CE-IVD mark

Analyst Comment 18.03.2026, 07.41 by Antti Siltanen
Aiforia Technologies

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Aiforia H2’25: Green shoots on the clinical side

Video 16.03.2026, 10.29 by Antti Siltanen, Isa Hudd
Aiforia Technologies

Faron:

Research 12.03.2026, 09.27 by Antti Siltanen
Faron Pharmaceuticals

New partnership for Aiforia

Analyst Comment 11.03.2026, 07.49 by Antti Siltanen
Aiforia Technologies

Terms of Faron's rights offering have been published

Analyst Comment 11.03.2026, 07.33 by Antti Siltanen
Faron Pharmaceuticals

Bioretec is planning rights issue worth 5-15 MEUR

Analyst Comment 11.03.2026, 07.45 by Antti Siltanen
Bioretec

Aiforia H2'25: Green shoots on the clinical side

Research 09.03.2026, 09.51 by Antti Siltanen
Aiforia Technologies

Nightingale H1'26: Research projects accelerate H2

Research 06.03.2026, 10.44 by Antti Siltanen
Nightingale Health
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.